-
Epstein-Barr virus Vaccine Approved to Target Certain Cancers
12 May 2024 19:47 GMT
… is for adult patients with Epstein-Barr virus-positive advanced solid tumors who … patients with relapsed or refractory virus-positive hematoma.
This achievement, announced … ;s first approval of an Epstein-Barr virus (EBV)- related mRNA therapeutic cancer …
-
FDA Approves IND for mRNA Vaccine for Epstein-Barr Virus-Related Cancer
10 May 2024 17:06 GMT
… -043, the first and only Epstein-Barr virus-related mRNA cancer vaccine.1 … advanced [Epstein-Barr virus-related cancers,” noted a company press release.1 Epstein-Barr virus, a … type of herpes virus that causes infectious …
-
FDA Approves WGc-043, EB Virus-Related mRNA Therapeutic Cancer Vaccine
10 May 2024 17:28 GMT
… first approval of an Epstein-Barr (EB) virus-related mRNA therapeutic cancer … candidate vaccine that targets EB virus-related malignant tumors in … of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors. ClinicalTrials …
-
Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
14 May 2024 11:00 GMT
… treatment and prevention of virus-associated cancers that impact … therapies to patients with virus-associated cancers.” Mr. … treatment and prevention of virus-associated cancers that impact … (R/R) Epstein-Barr virus-positive (EBV+) lymphoma (NAVAL-1), …
-
Bats in China found to carry novel herpesviruses, hinting at cross-species transmission dangers
13 May 2024 04:45 GMT
… herpesviruses such as human cytomegalovirus, Epstein-Barr virus, Kaposi's sarcoma-associated …
-
Virios Therapeutics, Inc. (VIRI) Q1 2024 Earnings Call Transcript
12 May 2024 05:12 GMT
… of our therapies, notably an Epstein-Barr virus and Herpes simplex 1 may … targeting the SARS-CoV-2 virus itself as a unique approach … target the SARS-CoV-2 virus have failed to date to …
-
A Single Drop of Blood Could Soon Reveal Your Risk of Developing MS
10 May 2024 23:59 GMT
… in common viruses like the Epstein-Barr Virus (EBV). Previously linked to MS and … disorders, the relationship between the virus and the autoantibodies points to …
-
Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 20:05 GMT
… (R/R) Epstein-Barr virus-positive (EBV+) lymphoma Clinical Trial Updates: … (R/M) Epstein-Barr virus-positive (EBV+) nasopharyngeal carcinoma (NPC). … that are epigenetically silenced in Epstein-Barr virus (EBV)-associated malignancies. Nanatinostat …
-
Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
09 May 2024 20:08 GMT
… immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to … therapy. It consists of allogeneic Epstein-Barr virus (EBV)-sensitized T cells that …
Atara is focused on applying Epstein-Barr virus (EBV) T-cell biology, featuring …
-
FDA Roundup: Myhibbin for Prophylaxis of Organ Rejection, Insulin App Recall
10 May 2024 22:39 GMT
… Moderna’s investigational respiratory syncytial virus (RSV) vaccine due to administrative … IND for mRNA Vaccine for Epstein-Barr Virus-Related Cancer
The FDA approved … -043, the first and only Epstein-Barr virus-related mRNA cancer vaccine. The …